Home > Press/Media > Press releases > Archive
Archive: Press Releases
Use the links below to download all recent AFFiRiS press releases . Adobe Reader is needed to view them.
Press release: December 05, 2011
AFFIRIS AG Invests Into Human Capital Chief Business Officer Recruited
Press release: November 08, 2011
Capital Increase: AFFiRiS Brings Santo VC and MIG 11 on Board
Press release: May 31, 2011
The Michael J. Fox Foundation Awards Affiris $1.5 Million for the clinical development of the first ParkinsonīS Disease Vaccine
Press release: May 31, 2011
AFFiRiS AG strengthens its development pipeline with the foundation of a Christian-Doppler-Laboratory
Press release: March 11, 2011
Alzheimer’s Vaccination Shows Promising Results
Press release: February 28, 2011
AFFiRiS announces an extension of its existing Alzheimer's disease vaccine development collaboration with GlaxoSmithKline triggering a Euro 3.5 million payment to AFFiRiS
Press release: December 16, 2010
Michael J. Fox Foundation funds AFFiRiS AG to develop Parkinson’s Vaccine
Press release: April 23, 2010
AFFiRiS AG: Alzheimer's vaccine AD02 already in clinical phase II
Press release: March 30, 2010
Parkinson vaccination: Good start to the spring for AFFiRiS AG
Press release: February 25, 2010
Vaccination against hypertension is development project No. 4 and has already been awarded a FFG grant of up to EUR 1.2 million
Press release: October 20, 2009
AFFiRiS AG – Encouraging Results from Phase I Studies of Two Alzheimer's Candidate Vaccines Trigger a EUR 10 Million Milestone Payment
Press release: May 27, 2009
AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
Press release: December 22, 2008
AFFiRiS begins development of a Parkinson's vaccine
Press release: October 23, 2008
GlaxoSmithKline and AFFiRiS sign an exclusive licence and option agreement for therapeutic Alzheimer’s disease candidate vaccines
Press release: July 16, 2008
AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer’s Vaccine
Press release: April 28, 2008
AFFiRiS in Biotech Spotlight 2008 – Independent Analysis Confirms Global Potential of Company’s Technology
Press release: March 18, 2008
AFFiRiS Uses Definiens Technology in Fight Against Alzheimer’s Disease
Presse release: February 27, 2008
AFFiRiS Expands Patent Portfolio for Alzheimer’s Therapies
